Concorde Asset Management’s State Street SPDR S&P Pharmaceuticals ETF XPH Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-6,526	Closed	-$284K	–	124
2017 Q4	$284K	Sell	6,526 -1,340	-17%	-$57K	0.36%	87
2017 Q3	$340K	Sell	7,866 -974	-11%	-$41.3K	0.29%	97
2017 Q2	$380K	Sell	8,840 -1,038	-11%	-$43.8K	0.51%	71
2017 Q1	$410K	Sell	9,878 -2,735	-22%	-$111K	0.68%	52
2016 Q4	$429K	Sell	12,613 -2,013	-14%	-$81.9K	0.77%	50
2016 Q3	$646K	Sell	14,626 -1,721	-11%	-$78.1K	0.81%	37
2016 Q2	$629K	Sell	16,347 -4,360	-21%	-$185K	0.63%	37
2016 Q1	$843K	Sell	20,707 -4,405	-18%	-$187K	0.97%	28
2015 Q4	$1.29M	Sell	25,112 -426	-2%	-$21.7K	1.43%	20
2015 Q3	$1.2M	Buy	25,538 +1,674	+7%	+$101K	2.03%	13
2015 Q2	$1.49M	Buy	+23,864	New	+$1.49M	1.89%	17